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Melatonin (7V-acetyl-5-methoxytryptamine), is the principal hormone of the pineal gland, 
and is produced mainly at night [1]. Melatonin plays a major role in the control of circadian 
rhythms and the regulation of seasonal cycles[l]. These effects are achieved through the bind­
ing of the hormone to its high affinity G-protein coupled Melj receptor. Analogs of mela­
tonin may be useful in restoring disorganized circadian rhythms following jet-lag, shift-work, 
boosting the immune system and preventing cancer [2]. In this project, a series of novel N 
acetyl 2-phenyltryptamine-derived analogs have been synthesized with a 2-phenyl ring 
attached to the indole nitrogen by a carbon chain of 1, 2 or 3 methylene groups (Fig. 1). The 
binding affinities of these analogs at the M e l j
a
 and Melju receptor subtypes as well as their 
biological activity on Xenopus laevis melanophores were examined in pharmacological assays, 
revealing information about the stereoelectronic requirements of the Melj receptor and its 
subtypes [3]. 
2 , n = l , 5 R = H 5 , n = 2 , 5 R = OMe 
3 , n = l , 5 R = OMe 6, η = 3, 5R = H 
4,n = 2, 5 R = H 7 , n = 3 , 5 R = OMe 
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